Understanding AI’s Expanding Role in Drug Discovery and Life Sciences R&D - Liran Belenzon of BenchSci

Understanding AI’s Expanding Role in Drug Discovery and Life Sciences R&D - Liran Belenzon of BenchSci

0 Calificaciones
0
Episodio
914 of 1034
Duración
19min
Idioma
Inglés
Formato
Categoría
Economía y negocios

Today’s guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is transforming disease biology research, streamlining scientific workflows, and enabling better decision-making in pharmaceutical R&D. Liran shares insights into the biggest challenges facing drug discovery today, including the complexity of disease biology and the critical role AI plays in unraveling it. He breaks down how AI-driven knowledge graphs, ontological models, and multimodal AI systems are improving both the speed and quality of scientific research. This episode is sponsored by BenchSci. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.


Escucha y lee

Descubre un mundo infinito de historias

  • Lee y escucha todo lo que quieras
  • Más de 900,000 títulos
  • Títulos exclusivos + Storytel Originals
  • 7 días de prueba gratis, luego $169 MXN al mes
  • Cancela cuando quieras
Suscríbete ahora
Copy of Device Banner Block 894x1036 3
Cover for Understanding AI’s Expanding Role in Drug Discovery and Life Sciences R&D - Liran Belenzon of BenchSci

Otros podcasts que te pueden gustar...